PIPE-791

Contineum Therapeutics Affirms Phase 2 Milestones and Cash Runway

SAN DIEGO, July 30, 2026 Contineum Therapeutics, Inc. reported its second-quarter 2026 financial results while reaffirming key clinical development...

By cGxPwire Editor
August 1, 2026

Bio-Pharma

Contineum Therapeutics Publishes PIPE-791 Discovery Study

SAN DIEGO, June 30, 2026 Contineum Therapeutics, Inc. announced the publication of its scientific manuscript describing the discovery and...

By cGxPwire Editor
July 2, 2026

Bio-Pharma

Contineum Therapeutics Reports Positive PIPE-791 Data

SAN DIEGO, April 30, 2026 Contineum Therapeutics, Inc. announced positive topline results from its Phase 1b clinical trial of...

By cGxPwire Editor
May 2, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Contineum Therapeutics Affirms Phase 2 Milestones and Cash Runway

Contineum Therapeutics Publishes PIPE-791 Discovery Study

Contineum Therapeutics Reports Positive PIPE-791 Data